Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125262811 | 12526281 | 1 | I | 20160628 | 20160629 | 20160705 | 20160705 | PER | US-PFIZER INC-2016324842 | PFIZER | 52.00 | YR | F | Y | 75.75000 | KG | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125262811 | 12526281 | 1 | PS | DEMEROL | MEPERIDINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 12.5 MG, TWO DOSES TEN MINUTES APART | Y | 567753A | 21171 | 12.5 | MG | SOLUTION FOR INJECTION | |||||
| 125262811 | 12526281 | 2 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | UNK | 0 | ||||||||||
| 125262811 | 12526281 | 3 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | UNK | 0 | ||||||||||
| 125262811 | 12526281 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | ||||||||
| 125262811 | 12526281 | 5 | C | NOVOLIN NPH | INSULIN HUMAN | 1 | 25 IU, UNK | 0 | 25 | IU | INJECTION | ||||||||
| 125262811 | 12526281 | 6 | C | LANTUS | INSULIN GLARGINE | 1 | 40 IU, UNK | 0 | 40 | IU | INJECTION | ||||||||
| 125262811 | 12526281 | 7 | C | NOVOLIN R | INSULIN HUMAN | 1 | 10 IU, UNK | 0 | 10 | IU | |||||||||
| 125262811 | 12526281 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | ||||||||
| 125262811 | 12526281 | 9 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125262811 | 12526281 | 10 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 2 MG, 3X/DAY | 0 | 2 | MG | TID | |||||||
| 125262811 | 12526281 | 11 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | ||||||||
| 125262811 | 12526281 | 12 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 125262811 | 12526281 | 13 | C | LORTAB | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 10/325MG [HYDROCODONE BITARTRATE, 10MG]/[PARACETAMOL, 325MG] | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125262811 | 12526281 | 1 | Procedural pain |
| 125262811 | 12526281 | 2 | Myocardial infarction |
| 125262811 | 12526281 | 3 | Gastrooesophageal reflux disease |
| 125262811 | 12526281 | 4 | Myocardial infarction |
| 125262811 | 12526281 | 5 | Diabetes mellitus |
| 125262811 | 12526281 | 6 | Diabetes mellitus |
| 125262811 | 12526281 | 7 | Diabetes mellitus |
| 125262811 | 12526281 | 8 | Hypertension |
| 125262811 | 12526281 | 9 | Cardiac disorder |
| 125262811 | 12526281 | 11 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125262811 | 12526281 | Pruritus | |
| 125262811 | 12526281 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125262811 | 12526281 | 1 | 20160628 | 0 |